Q/C Technologies, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Q/C Technologies, Inc. (QCLS) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 14.57 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-12
- Q/C Technologies, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 14.57M shares, a 854.61% increase year-over-year.
- Q/C Technologies, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 14.44M shares, a 53.83% decline year-over-year.
- Q/C Technologies, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 7.48M shares, a 28.89% decline year-over-year.
- Q/C Technologies, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 1.53M shares, a 95.55% decline year-over-year.
- Q/C Technologies, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 8.63M shares, a 23.58% decline from fiscal 2024.
- Q/C Technologies, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 11.29M shares, a 34.57% increase from fiscal 2023.
- Q/C Technologies, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 8.39M shares, a 1699.53% increase from fiscal 2022.
- Q/C Technologies, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 466.25K shares, a 96.31% decline from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 14.57M shares 10-Q · filed 2026-08-12 | 14.78M shares 10-Q · filed 2026-08-12 | ||||||
| 2026-03-31 | 14.44M shares 10-Q · filed 2026-05-15 | |||||||
| 2025-12-31 | 8.63M shares 10-K · filed 2026-04-15 | |||||||
| 2025-09-30 | 7.48M shares 10-Q · filed 2025-11-19 | 5.14M shares 10-Q · filed 2025-11-19 | ||||||
| 2025-06-30 | 1.53M shares 10-Q · filed 2026-08-12 | 318.14M shares 10-Q · filed 2025-08-19 | 1.12M shares 10-Q · filed 2026-08-12 | 276.98M shares 10-Q · filed 2025-08-19 | ||||
| 2025-03-31 | 31.28M shares 10-Q · filed 2026-05-15 | 161.87M shares 10-Q · filed 2025-05-15 | ||||||
| 2024-12-31 | 11.29M shares 10-K · filed 2026-04-15 | 47.11M shares 10-K · filed 2025-04-11 | ||||||
| 2024-09-30 | 10.52M shares 10-Q · filed 2025-11-19 | 34.25M shares 10-Q · filed 2024-11-14 | 9.68M shares 10-Q · filed 2025-11-19 | 34.25M shares 10-Q · filed 2024-11-14 | ||||
| 2024-06-30 | 34.31M shares 10-Q · filed 2025-08-19 | 34.31M shares 10-Q · filed 2025-08-19 | ||||||
| 2024-03-31 | 6.64M shares 10-Q · filed 2025-05-15 | |||||||
| 2023-12-31 | 8.39M shares 10-K · filed 2025-04-11 | 8.48M shares 10-K · filed 2024-04-01 | ||||||
| 2023-09-30 | 357.64K shares 10-Q · filed 2024-11-14 | 24.54M shares 10-Q · filed 2023-11-14 | 8.18M shares 10-Q · filed 2024-11-14 | 24.54M shares 10-Q · filed 2023-11-14 | ||||
| 2023-06-30 | 24.61M shares 10-Q · filed 2023-08-14 | 9.00M shares 10-Q · filed 2024-08-19 | 24.61M shares 10-Q · filed 2023-08-14 | |||||
| 2023-03-31 | 9.90M shares 10-Q · filed 2024-05-15 | 27.19M shares 10-Q · filed 2023-05-15 | ||||||
| 2022-12-31 | 466.25K shares 10-K · filed 2024-04-01 | 13.89M shares 10-K · filed 2023-03-31 | ||||||
| 2022-09-30 | 13.89M shares 10-Q · filed 2023-11-14 | 11.10M shares 10-Q · filed 2022-11-10 | 13.89M shares 10-Q · filed 2023-11-14 | |||||
| 2022-06-30 | 12.54M shares 10-Q · filed 2023-08-14 | 12.54M shares 10-Q · filed 2023-08-14 | ||||||
| 2022-03-31 | 12.44M shares 10-Q · filed 2023-05-15 | |||||||
| 2021-12-31 | 12.63M shares 10-K · filed 2023-03-31 | |||||||
| 2021-09-30 | 10.09M shares 10-Q · filed 2022-11-10 | 10.09M shares 10-Q/A · filed 2021-11-15 | ||||||
| 2021-06-30 | 10.14M shares 10-Q · filed 2022-08-15 | 10.14M shares 10-Q · filed 2022-08-15 | ||||||
| 2021-03-31 | 4.19M shares 10-Q · filed 2022-05-16 | 6.91M shares 10-Q · filed 2021-05-18 | ||||||
| 2020-12-31 | 4.19M shares 10-K · filed 2022-03-31 | 12.88M shares 10-K · filed 2021-03-01 | ||||||
| 2020-09-30 | 3.82M shares 10-Q/A · filed 2021-11-15 | 3.82M shares 10-Q/A · filed 2021-11-15 | 1.43M shares 10-Q · filed 2020-11-16 | |||||
| 2020-06-30 | 3.11M shares 10-Q · filed 2021-08-16 | 1.59M shares 10-Q · filed 2020-08-14 | 3.11M shares 10-Q · filed 2021-08-16 | 1.59M shares 10-Q · filed 2020-08-14 | ||||
| 2020-03-31 | 1.24M shares 10-Q · filed 2021-05-18 | 2.49M shares 10-Q · filed 2020-05-15 | ||||||
| 2019-12-31 | 3.05M shares 10-K · filed 2021-03-01 | |||||||
| 2019-09-30 | 2.49M shares 10-Q · filed 2019-11-14 | 103.66K shares 10-Q · filed 2020-11-16 | 2.49M shares 10-Q · filed 2019-11-14 | |||||
| 2019-06-30 | 103.91K shares 10-Q · filed 2020-08-14 | 103.91K shares 10-Q · filed 2020-08-14 | 2.49M shares 10-Q · filed 2019-08-14 | |||||
| 2019-03-31 | 103.91K shares 10-Q · filed 2020-05-15 | 2.49M shares 10-Q · filed 2019-05-20 | ||||||
| 2018-12-31 | 88.46K shares 10-K · filed 2020-03-25 | 2.12M shares 10-K · filed 2019-04-01 | ||||||
| 2018-09-30 | 1.43M shares 10-Q · filed 2019-11-14 | 1.43M shares 10-Q · filed 2019-11-14 | ||||||
| 2018-06-30 | 11.53M shares 10-Q · filed 2018-08-14 | 1.44M shares 10-Q · filed 2019-08-14 | 11.53M shares 10-Q · filed 2018-08-14 | |||||
| 2018-03-31 | 2.41M shares 10-Q · filed 2019-05-20 | |||||||
| 2017-12-31 | 6.22M shares 10-K · filed 2019-04-01 | |||||||
| 2017-09-30 | 219.34K shares 10-Q · filed 2018-11-14 | 219.34K shares 10-Q · filed 2018-11-14 | ||||||
| 2017-06-30 | 1.76M shares 10-Q · filed 2018-08-14 | 1.76M shares 10-Q · filed 2018-08-14 | ||||||
| 2016-09-30 | 175.00K shares 10-Q · filed 2016-11-14 | 175.00K shares 10-Q · filed 2016-11-14 | ||||||
| 2015-09-30 | 175.00K shares 10-Q · filed 2016-11-14 | 175.00K shares 10-Q · filed 2016-11-14 | ||||||
| 2014-03-31 | 1.99K shares 10-Q · filed 2014-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |